R obert B. Ford (NYSE:F), Chairman and CEO of Abbott Laboratories (NYSE:ABT), recently sold a significant portion of his holdings in the company. According to a Form 4 filing with the Securities ...

In this article, we are going to take a look at where Abbott Laboratories (NYSE ... He also commented on a shareholder letter from bank CEO David Solomon. Cramer opined that most banking officials ...

US medical device company Abbott has said it plans to launch a new range of 'biowearable' health devices aimed at consumers, in a move that builds on its expertise in glucose monitoring.

The decision to allow a new trial could have  implications for both the companies and families with babies born prematurely.